Avasimibe exerts anticancer effects on human glioblastoma cells via inducing cell apoptosis and cell cycle arrest

[1]  S. Goel,et al.  CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest. , 2018, Trends in cell biology.

[2]  Tengfei Ji,et al.  3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase , 2018, Journal of Experimental & Clinical Cancer Research.

[3]  Jingwei Tian,et al.  H6, a novel hederagenin derivative, reverses multidrug resistance in vitro and in vivo , 2018, Toxicology and applied pharmacology.

[4]  N. Ali,et al.  MicroRNAs as biomarkers for human glioblastoma: progress and potential , 2018, Acta Pharmacologica Sinica.

[5]  F. Yamasaki,et al.  Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide. , 2017, Journal of neurosurgery.

[6]  G. Reifenberger,et al.  Advances in the molecular genetics of gliomas — implications for classification and therapy , 2017, Nature Reviews Clinical Oncology.

[7]  M. J. van den Bent,et al.  Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma , 2016, Neuro-oncology.

[8]  Hui Liu,et al.  Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks , 2016, BMC Bioinformatics.

[9]  Wei Yang,et al.  Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism , 2016, Nature.

[10]  Jiandong Chen.  The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression. , 2016, Cold Spring Harbor perspectives in medicine.

[11]  H. Um.  Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species , 2015, Oncotarget.

[12]  Mitchel S. Berger,et al.  Current and future strategies for treatment of glioma , 2016, Neurosurgical Review.

[13]  D. Green,et al.  Cell Death Signaling. , 2015, Cold Spring Harbor perspectives in biology.

[14]  L. Morgan,et al.  The epidemiology of glioma in adults: a "state of the science" review. , 2015, Neuro-oncology.

[15]  S. Tait,et al.  Mitochondrial apoptosis: killing cancer using the enemy within , 2015, British Journal of Cancer.

[16]  A. Roy,et al.  p27 and Leukemia: Cell Cycle and Beyond , 2015, Journal of cellular physiology.

[17]  J. Crispino,et al.  The Aurora Kinases in Cell Cycle and Leukemia , 2014, Oncogene.

[18]  R. Winn,et al.  The soft agar colony formation assay. , 2014, Journal of visualized experiments : JoVE.

[19]  J. Barnholtz-Sloan,et al.  The epidemiology of glioma in adults: a "state of the science" review. , 2014, Neuro-oncology.

[20]  R. Medema,et al.  Bora and Aurora-A continue to activate Plk1 in mitosis , 2014, Journal of Cell Science.

[21]  Jing Wang,et al.  Teaching an old dog new tricks: drug repositioning in small cell lung cancer. , 2013, Cancer discovery.

[22]  J. Maurice.  Teaching old drugs new tricks raises hopes of new treatment for lung cancer. , 2013, The Lancet Respiratory Medicine.

[23]  M. Brassesco,et al.  Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation. , 2013, Cancer biotherapy & radiopharmaceuticals.

[24]  Marta Cascante,et al.  Targeting cell cycle regulation in cancer therapy. , 2013, Pharmacology & therapeutics.

[25]  David G Hendrickson,et al.  Differential analysis of gene regulation at transcript resolution with RNA-seq , 2012, Nature Biotechnology.

[26]  R A Knight,et al.  Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 , 2011, Cell Death and Differentiation.

[27]  Viagra and Cialis for heart failure? Erectile dysfunction drugs may do what no others have done. , 2012, Harvard heart letter : from Harvard Medical School.

[28]  Jyh-Yih Chen,et al.  Pardaxin, an Antimicrobial Peptide, Triggers Caspase-Dependent and ROS-Mediated Apoptosis in HT-1080 Cells , 2011, Marine drugs.

[29]  Yu-Quan Wei,et al.  Integrated computational model of cell cycle and checkpoint reveals different essential roles of Aurora-A and Plk1 in mitotic entry. , 2011, Molecular bioSystems.

[30]  Sana Bemlih,et al.  Acyl-coenzyme A: Cholesterol acyltransferase inhibitor Avasimibe affect survival and proliferation of glioma tumor cell lines , 2010, Cancer biology & therapy.

[31]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[32]  Stephen S. Taylor,et al.  Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery , 2008, Nature.

[33]  J. Yates,et al.  Bora and the Kinase Aurora A Cooperatively Activate the Kinase Plk1 and Control Mitotic Entry , 2008, Science.

[34]  Rebecca C Taylor,et al.  Apoptosis: controlled demolition at the cellular level , 2008, Nature Reviews Molecular Cell Biology.

[35]  D. Brautigan,et al.  Aurora-A Kinase and Inhibitor-2 Regulate the Cyclin Threshold for Mitotic Entry in Xenopus Early Embryonic Cell Cycles , 2006, Cell cycle.

[36]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[37]  Fernando Alfonso,et al.  Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions , 2004, Circulation.

[38]  Eiji Kohmura,et al.  Aurora-A Kinase Maintains the Fidelity of Early and Late Mitotic Events in HeLa Cells* , 2003, Journal of Biological Chemistry.

[39]  M. C. Okafor.  Thalidomide for Erythema Nodosum Leprosum and Other Applications , 2003, Pharmacotherapy.

[40]  O. Coqueret,et al.  New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? , 2003, Trends in cell biology.

[41]  D. Sprecher,et al.  Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia. , 2001, Atherosclerosis.

[42]  J. Jukema,et al.  Its Cholesterol-Lowering Effect in ApoE * 3-Leiden Mice Acyl-CoA : Cholesterol Acyltransferase Inhibitor Avasimibe Reduces Atherosclerosis in Addition to , 2001 .

[43]  M. Milad,et al.  Preclinical safety evaluation of avasimibe in beagle dogs: an ACAT inhibitor with minimal adrenal effects. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  M Brada,et al.  Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[45]  A. Fornace,et al.  The GADD45 Inhibition of Cdc2 Kinase Correlates with GADD45-mediated Growth Suppression* , 2000, The Journal of Biological Chemistry.

[46]  C. Harris,et al.  GADD45 induction of a G2/M cell cycle checkpoint. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Longo,et al.  Cell Cycle Regulation of the Human Polo-like Kinase (PLK) Promoter* , 1997, The Journal of Biological Chemistry.

[48]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[49]  Y. Xiong,et al.  Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. , 1994, Oncogene.

[50]  G. Hannon,et al.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.

[51]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[52]  P. Nurse,et al.  Animal cell cycles and their control. , 1992, Annual review of biochemistry.